← Back to Dashboard

SUNPHARMA Sun Pharmaceutical Industries Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 1.66%
₹ 1,902.40
-0.08%
1-year price · range ₹1,579–₹1,990

Live setups screens SUNPHARMA is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Long Buildup
Derivative traders are adding fresh longs (OI up +1.4%) on price strength (+0.5%).

Analysis what the data is telling us about SUNPHARMA

In the last completed session, Sun Pharmaceutical Industries Ltd. closed +0.51% with futures open interest moving +1.4%. That combination — price rising while OI builds — is classified as a Long Buildup, meaning derivative traders are adding fresh bullish positions into strength rather than merely covering existing shorts. The stock's option PCR sits at 0.54, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,940 sits 2.0% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Sun Pharmaceutical Industries Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Sun Pharmaceutical Industries Ltd. suggests upside momentum is building.

F&O Positioning EOD derivatives setup

Buildup Class
Long Buildup
bias: bullish
Futures OI
18,297,300
+262150 (+1.4%)
Option PCR (OI)
0.54
heavy call writing
Max Pain Strike
₹ 1,940
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,904.00
yesterday's EOD close
Index Contribution
-0.001 pp
contribution to Nifty
Traded Volume
1,491,953
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 400 sessions of price history

RSI (14)
43.4
neutral momentum
52-Week High
₹ 2,046.90
-7.0% from high
52-Week Low
₹ 1,548.00
+23.0% above low
200-DMA
₹ 1,793.23
+6.2% · above trend
50-DMA
₹ 1,911.80
-0.4% from 50-DMA
1-Year Return
+16.6%
1M -2.0%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
37.7
price / earnings
P/B
5.5
price / book
ROE
return on equity
Market Cap
₹ 456,449 Cr
total market value
Dividend Yield
0.84%
trailing yield
EPS (TTM)
₹ 50.46
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

Date Side Price Value (Cr) Counterparty
2026-06-24 BUY ₹ 1,868.00 28.85 THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794
2026-06-24 SELL ₹ 1,868.00 28.85 THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-08-25 · spot 1,904 · EOD 2026-08-20

Option writers expect range between 1,860 and 2,000+5.0% upside, -2.3% downside.
upside-skewed
Call OI (writers) Strike Put OI (writers)
350
IV 148% Δ 0.70 θ -13.1 ν 1
1780
28,000 -1k
19,250 -1k
1800
253,400 -6k
43,050 -1k
1820
235,200 -26k
26,950 -1k
1840
183,750 +22k
80,500 -9k
1860 S
560,350 -16k
IV 21% Δ -0.13 θ -1.1 ν 0
179,550 -43k
IV 12% Δ 0.86 θ -0.9 ν 0
1880
207,550 -15k
IV 20% Δ -0.26 θ -1.5 ν 1
406,700 -221k
IV 16% Δ 0.57 θ -1.7 ν 1
1900
374,850 -3k
IV 20% Δ -0.44 θ -1.9 ν 1
535,500 -198k
IV 17% Δ 0.34 θ -1.7 ν 1
1920
201,250 -97k
IV 23% Δ -0.62 θ -2.0 ν 1
662,200 -41k
IV 18% Δ 0.18 θ -1.2 ν 1
1940 MP
396,900 -19k
IV 25% Δ -0.75 θ -1.7 ν 1
1,024,450 -54k
1960
480,550 -51k
IV 27% Δ -0.83 θ -1.4 ν 0
674,450 -54k
1980
168,700 -6k
IV 33% Δ -0.86 θ -1.6 ν 0
1,202,600 -61k
2000 R
233,800 -5k
IV 41% Δ -0.87 θ -1.9 ν 0
555,100 -28k
2020
140,000
IV 68% Δ -0.78 θ -4.7 ν 1

Chain Interpretation

Spot Underlying 1,903.99
Key Resistance (R) 2,000
Key Support (S) 1,860
Max Pain Strike (MP) 1,940
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for SUNPHARMA options · 2026-08-25 expiry

Underlying: SUNPHARMA · Spot: ₹ 1,903.99 · Expiry: 2026-08-25 · Lot: 350

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

SUNPHARMA — frequently asked questions

What is the Sun Pharmaceutical Industries Ltd. share price today?

SUNPHARMA is trading at ₹1,902.40 (-0.08% vs previous close), per the latest update on this page.

What is the P/E ratio of Sun Pharmaceutical Industries Ltd.?

SUNPHARMA (Sun Pharmaceutical Industries Ltd.) has a trailing twelve-month P/E ratio of 37.7.

What is the market cap of Sun Pharmaceutical Industries Ltd.?

SUNPHARMA has a market capitalisation of approximately ₹456,449 crore.

Is SUNPHARMA near its 52-week high?

SUNPHARMA is trading -7.0% from its 52-week high of ₹2,046.90 as of 2026-08-20.

What is the RSI of SUNPHARMA?

The 14-day RSI of SUNPHARMA is 43.4, which is considered neutral.

Is SUNPHARMA above its 200-day moving average?

SUNPHARMA is trading above its 200-DMA of ₹1,793.23 (+6.2% away).

What is the F&O buildup in SUNPHARMA?

The latest end-of-day derivatives data classifies SUNPHARMA as Long Buildup (bias: bullish), based on the day's combined price and open-interest change.

What is the max pain and PCR for SUNPHARMA options?

SUNPHARMA's option-chain max pain strike is ₹1,940 and its put-call ratio (OI) is 0.54, from the latest end-of-day option chain.

Are FIIs or big investors buying SUNPHARMA?

Strota tracks every bulk and block deal in SUNPHARMA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.